Background

CAN-Implement© is a structured and systematic process informed by the Knowledge to Action Model (ncbi.nlm.nih.gov/pubmed/23796066) to support health practitioners, frontline managers or policy makers in adapting clinical practice guidelines for local use.

CAN-Implement© provides detailed guidance on how to adapt evidence or best practice recommendations to local context and plan for implementation. It includes support materials and resources that can assist users to facilitate three core phases of evidence implementation:

  • Identification and clarification of the practice issue/problem
  • Solution building, and
  • Implementation, Evaluation and Sustainability

An online version, CAN-Implement.Pro©, was developed to enable greater dissemination and utilisation of the CAN-Implement© process. It is open-access (non-commercialised); designed to assist users in guideline implementation. The user interface consists of three phases with the steps from CAN-Implement© embedded as points of guided interaction that clearly establishes the role of implementation planning at the commencement of a guideline project. The facilitation components have been integrated to enhance accessibility within each phase and step, and includes access to a high level public web forum to enable users across the world to communicate on regional issues or collaborate in a shared learning context.

The Study Methods

This is a three-phase study (figure 1); participation in phase one does not imply on-going participation. Purposively selected participants from phase one will be invited to continue with future phases. Participants in phase one are welcome to contact the research team to indicate interest in continued participation.

Figure 1: overview of methods, phases 1-3
All phases of the research meet ERB ethics requirements for confidentiality, anonymity, and the project has been classified as ‘low risk’ with the ERB ID Number H-2016-157.

Study aims:

  • To develop a contextual and demographic profile of potential users, and their initial perceptions of and intention to use CAN-Implement.Pro© for facilitating evidence customisation and implementation planning.
  • To undertake a process evaluation of CAN-Implement.Pro© using a purposively selected case series methodology.
  • To undertake a mixed methods evaluation of the facilitation elements, tools and resources built in to the CAN-Implement.Pro©

Methods

Phase I:
Participants will include groups such as guideline development groups or professional associations, academics, researchers, health practitioners, and policy makers who are interested in using CAN-Implement© and CAN-Implement.Pro© as a framework and a medium to facilitate their evidence implementation activity. These could either be groups who have identified evidence-based recommendations to address a clinical problem but are uncertain of how to proceed with their implementation or those who have yet to determine which evidence-based recommendations to address a clinical problem and are uncertain of how they could be implemented.

Phase II:
Groups (i.e. cases) will be purposively selected from Phase I participants. Selection of cases will aim for maximum variation so that a diverse range of cases can be studied. Groups from different geographical settings, health disciplines, scope of implementation, clinical area (e.g. cardiovascular, oncology, neurology), population of interest, and focus of health care (e.g. treatment, assessment, prevention) will be invited to participate in the study.

Phase III:
This study will include health professionals who consented to being contacted for follow-up. The focus is on facilitation of implementation practices and activities of health professionals and others involved in the development of guidelines for policy and practice.

Contact us:

Primary contact address: [email protected]

  1. PI Dr Craig Lockwood
  2. CI Dr Lucylynn Lizerondo
  3. CI Emeritus Professor Margaret Harrison (PDF)
  4. CI Dr Ian Graham

Further reading

Links pending

 Enrolment Inquiry